Topical Minocycline Foam (FMX-103) for the Treatment of Moderate-to-Severe Rosacea: Results of a Phase 2, Randomized, Double-Blind, Multicenter Clinical Study

Main Article Content

Ulrich Mrowietz
Tal Hetzroni Kedem
Rita Kenyan
Meir Eini
Dov Tamarkin
Mitchell Shirvan


rosacea, minocycline, randomized, clinical trial


Abstract Not Available

Most read articles by the same author(s)